The ‘Switch’ study protocol: A randomisedcontrolled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug

Định dạng: pdf / Số trang: 15

Nhắn tin với admin nếu không tải được